UniQure Vs. Spark Therapeutics: One Has Better Timing, The Other Has Better Efficacy
December 05, 2016 at 13:15 PM EST
Gbola Amusa of Chardan Capital said although the AAV-based gene therapy (GT) of Uniqure NV (NASDAQ: QURE has better timing, Spark ...